Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017, Article ID 1564819, 4 pages
https://doi.org/10.1155/2017/1564819
Case Report

Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR

1Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan
2Department of Medical Oncology, Funabashi Municipal Medical Center, Chiba, Japan
3Department of Pathology, Funabashi Municipal Medical Center, Chiba, Japan

Correspondence should be addressed to Satoshi Hirano; pj.abihc.ihsabanuf.cmm@onarihs

Received 9 September 2017; Accepted 23 November 2017; Published 28 December 2017

Academic Editor: Jeanine M. Buchanich

Copyright © 2017 Asako Yanagisawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Wolin, “Challenges in the diagnosis and management of well-differentiated neuroendocrine tumors of the lung (typical and atypical carcinoid): current status and future considerations,” Oncologist, vol. 20, no. 10, pp. 1123–1131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Halperin, C. Shen, A. Dasari et al., “Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study,” Lancet Oncology, vol. 18, no. 4, pp. 525–534, 2017. View at Publisher · View at Google Scholar
  3. M. E. Pavel, J. D. Hainsworth, E. Baudin et al., “Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study,” The Lancet, vol. 378, no. 9808, pp. 2005–2012, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Rinke, H. H. Müller, C. Schade-Brittinger et al., “Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group,” Journal of Clinical Oncology, vol. 27, no. 28, pp. 4656–4663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Asamura, T. Kameya, Y. Matsuno et al., “Neuroendocrine neoplasms of the lung: a prognostic spectrum,” Journal of Clinical Oncology, vol. 24, no. 1, pp. 70–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. C. Lee, N. C. Osakwe, N. Narula et al., “Predictors of disease-free survival and recurrence in patients with resected bronchial carcinoid tumors,” Thoracic and Cardiovascular Surgeon, vol. 64, no. 2, pp. 159–165, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Maurizi, M. Ibrahim, C. Andreetti et al., “Long-term results after resection of bronchial carcinoid tumour: evaluation of survival and prognostic factors,” Interactive Cardio Vascular and Thoracic Surgery, vol. 19, no. 2, pp. 239–244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. W. D. Travis, E. Brambilla, A. P. Burke et al., WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, International Agency for Research on Cancer, Lyon, France, 2015.
  9. M. G. Arrigoni, L. B. Woolner, and P. E. Bernatz, “A typical carcinoid tumors of the lung,” Journal of Thoracic and Cardiovascular Surgery, vol. 64, no. 3, pp. 413–421, 1972. View at Google Scholar
  10. W. D. Travis, W. Rush, D. B. Flieder et al., “Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid,” American Journal of Surgical Pathology, vol. 22, no. 8, pp. 934–944, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Lou, I. Sarkaria, C. Pietanza et al., “Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance,” Annals of Thoracic Surgery, vol. 96, no. 4, pp. 1156–1162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Gibril, J. C. Reynolds, J. L. Doppman et al., “Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study,” Annals of Internal Medicine, vol. 125, no. 1, pp. 26–34, 1996. View at Publisher · View at Google Scholar
  13. G. D. Slooter, A. Mearadji, W. A. Breeman et al., “Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours,” British Journal of Surgery, vol. 88, no. 1, pp. 31–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. G. D. Slooter, A. Mearadji, W. A. Breeman et al., “Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy,” Modern Pathology, vol. 20, no. 11, pp. 1172–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Caplin, E. Baudin, P. Ferolla et al., “Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids,” Annals of Oncology, vol. 26, no. 8, pp. 1604–1620, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Oberg, “Cancer: antitumor effects of octreotide LAR, a somatostatin analog,” Nature Reviews Endocrinology, vol. 6, no. 4, pp. 188-189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. L. Filosso, E. Ruffini, A. Oliaro et al., “Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide,” European Journal of Cardio-Thoracic Surgery, vol. 21, no. 5, pp. 913–917, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Caplin, M. Pavel, J. B. Ćwikła et al., “Lanreotide in metastatic enteropancreatic neuroendocrine tumors,” New England Journal of Medicine, vol. 371, no. 3, pp. 224–233, 2014. View at Publisher · View at Google Scholar · View at Scopus